---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-218879"
form_type: "8-K"
ticker: "OKUR"
cik: "0001637715"
company_name: "OnKure Therapeutics, Inc."
filed_at: "2024-09-13T23:59:59+00:00"
generated_at: "2026-05-31T04:55:28.163685+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Reneo Pharma terminates CDO Ashley Hall amid planned merger with OnKure

## Summary
- Ashley F. Hall, Chief Development Officer, terminated effective Sept 13, 2024.
- Termination linked to planned merger with OnKure, Inc. and cessation of drug development.
- Hall will receive severance benefits under previously disclosed severance plan.
- Merger with OnKure is expected to shift company away from historical drug development.
- Gregory J. Flesher remains CEO; no replacement for CDO announced.

## SEC filing metadata
- accession: 0001193125-24-218879
- form_type: 8-K
- ticker: OKUR
- cik: 0001637715
- company_name: OnKure Therapeutics, Inc.
- filed_at: 2024-09-13T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1637715/000119312524218879/0001193125-24-218879-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1637715/000119312524218879/d809509d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-218879
- JSON: https://secwatch.observer/filing/0001193125-24-218879.json
- Plain text: https://secwatch.observer/filing/0001193125-24-218879.txt

## Key facts
- Executive change
  Ashley F. Hall was terminated as Chief Development Officer at OnKure Therapeutics, Inc..
  - Action: terminated
  - Role: Chief Development Officer
  source text: the Company terminated the employment of Ashley F. Hall, J.D., the Company’s Chief Development Officer, effective as of September 13, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1637715/000119312524218879/0001193125-24-218879-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.